Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke

NCT02074111 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02074111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02074111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial atherosclerotic stroke, intracranial steno-occlusive disease, moyamoya disease